Antibacterial Activity of Electrospun Polyacrylonitrile Copper Nanoparticle Nanofibers on Antibiotic Resistant Pathogens and Methicillin Resistant
Methicillin-Resistant Staphylococcus aureus
antibacterial activity
copper
electrospinning
nanoparticles
polyacrylonitrile
Journal
Nanomaterials (Basel, Switzerland)
ISSN: 2079-4991
Titre abrégé: Nanomaterials (Basel)
Pays: Switzerland
ID NLM: 101610216
Informations de publication
Date de publication:
22 Jun 2022
22 Jun 2022
Historique:
received:
15
05
2022
revised:
14
06
2022
accepted:
18
06
2022
entrez:
9
7
2022
pubmed:
10
7
2022
medline:
10
7
2022
Statut:
epublish
Résumé
Bacteria induced diseases such as community-acquired pneumonia (CAP) are easily transmitted through respiratory droplets expelled from a person's nose or mouth. It has become increasingly important for researchers to discover materials that can be implemented in in vitro surface contact settings which disrupt bacterial growth and transmission. Copper (Cu) is known to have antibacterial properties and have been used in medical applications. This study investigates the antibacterial properties of polyacrylonitrile (PAN) based nanofibers coated with different concentrations of copper nanoparticles (CuNPs). Different concentrations of copper sulfate (CuSO
Identifiants
pubmed: 35807975
pii: nano12132139
doi: 10.3390/nano12132139
pmc: PMC9268565
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Am Fam Physician. 2005 Dec 15;72(12):2474-81
pubmed: 16370403
Clin Microbiol Rev. 2015 Jul;28(3):603-61
pubmed: 26016486
J Infect Dis. 2022 May 4;225(9):1561-1568
pubmed: 32301491
Int J Antimicrob Agents. 2006 Feb;27(2):87-96
pubmed: 16423509
Environ Res. 2021 Sep;200:111752
pubmed: 34302822
J Microbiol Immunol Infect. 2021 Oct 1;:
pubmed: 34635425
Microbiol Mol Biol Rev. 2016 Jun 15;80(3):629-61
pubmed: 27307579
Sci Rep. 2017 Mar 15;7:44554
pubmed: 28294164
Adv Prev Med. 2011;2011:124064
pubmed: 22162813
ACS Omega. 2019 Dec 27;5(1):98-103
pubmed: 31956756
Clin Infect Dis. 2018 Jul 2;67(2):303-309
pubmed: 29390132
Cell Microbiol. 2012 Oct;14(10):1513-21
pubmed: 22747834
Clin Infect Dis. 2016 Aug 1;63(3):300-9
pubmed: 27161775
Biologicals. 2014 Sep;42(5):237-59
pubmed: 24996452
Microbes Infect. 2021 May-Jun;23(4-5):104806
pubmed: 33684520
J Appl Microbiol. 2018 May;124(5):1032-1046
pubmed: 29280540
Curr Pharm Des. 2015;21(15):1930-43
pubmed: 25732666
Int J Hyg Environ Health. 2016 Oct;219(7 Pt A):585-591
pubmed: 27318723
Lancet Infect Dis. 2004 Mar;4(3):144-54
pubmed: 14998500
Can Vet J. 1997 Jul;38(7):429-37
pubmed: 9220132
Clin Infect Dis. 1992 Apr;14(4):801-7
pubmed: 1576274
J Hosp Infect. 2006 Jan;62(1):58-63
pubmed: 16099072
J Infect. 2021 Jan;82(1):76-83
pubmed: 33144192
Minerva Anestesiol. 2011 Feb;77(2):196-211
pubmed: 21242952
J R Soc Interface. 2009 Dec 6;6 Suppl 6:S697-702
pubmed: 19828499
Int J Mol Sci. 2015 Jan 19;16(1):2099-116
pubmed: 25607734
Nanotechnology. 2014 Apr 4;25(13):135101
pubmed: 24584282
Biotechnol Adv. 2010 May-Jun;28(3):325-47
pubmed: 20100560
MMWR Morb Mortal Wkly Rep. 2007 Apr 13;56(14):325-9
pubmed: 17431376
J Bone Joint Surg Am. 2009 Aug;91(8):1907-12
pubmed: 19651948
Curr Opin Colloid Interface Sci. 2021 Oct;55:101471
pubmed: 34093064
Nature. 1987 Feb 5-11;325(6104):536-7
pubmed: 3543690
Microbes Infect. 2002 Apr;4(4):481-9
pubmed: 11932199
Int J Antimicrob Agents. 2022 Mar;59(3):106525
pubmed: 35041940
Wkly Epidemiol Rec. 2013 Mar 15;88(11):126-7
pubmed: 23544239
Nat Rev Dis Primers. 2018 May 31;4:18033
pubmed: 29849094
Saudi Pharm J. 2021 Feb;29(2):121-133
pubmed: 33398228
Acta Biomater. 2020 Apr 15;107:25-49
pubmed: 32084600
N Engl J Med. 1998 Aug 20;339(8):520-32
pubmed: 9709046
J Hosp Med. 2010 Nov-Dec;5(9):528-34
pubmed: 20734457
Infect Immun. 1998 Jul;66(7):3170-8
pubmed: 9632582
Int J Health Plann Manage. 2021 Mar;36(2):257-266
pubmed: 33295073
Int J Antimicrob Agents. 2007 Nov;30(5):385-9
pubmed: 17716872
PLoS One. 2012;7(1):e30394
pubmed: 22291948
Am J Infect Control. 1987 Dec;15(6):249-65
pubmed: 3326432
Nanotoxicology. 2020 Jun;14(5):683-695
pubmed: 32189538
N Engl J Med. 2014 Oct 23;371(17):1619-28
pubmed: 25337751
J Orthop Res. 2021 Oct;39(10):2141-2150
pubmed: 33274775
J Control Release. 2015 Dec 10;219:536-547
pubmed: 26450667
J Endod. 2004 May;30(5):315-20
pubmed: 15107642
J Clin Invest. 2014 Jul;124(7):2836-40
pubmed: 24983424
Am J Clin Nutr. 1998 May;67(5 Suppl):952S-959S
pubmed: 9587135
Nat Rev Microbiol. 2019 Apr;17(4):203-218
pubmed: 30737488
Lancet Infect Dis. 2021 Sep;21(9):1313-1323
pubmed: 33894131
ACS Appl Mater Interfaces. 2018 May 9;10(18):15477-15486
pubmed: 29637776
Braz J Med Biol Res. 2009 Aug;42(8):756-60
pubmed: 19578704
Lancet. 2020 Jun 27;395(10242):1973-1987
pubmed: 32497510
Clin Microbiol Infect. 2006 Mar;12 Suppl 1:16-23
pubmed: 16445720
J Infect Dis. 2007 Sep 15;196(6):919-27
pubmed: 17703424
J Clin Med. 2020 Jan 19;9(1):
pubmed: 31963877
Semin Immunopathol. 2012 Mar;34(2):201-14
pubmed: 22095240
Front Med (Lausanne). 2021 Sep 03;8:732047
pubmed: 34540873
Lancet. 1998 Oct 17;352(9136):1295-302
pubmed: 9788476
N Engl J Med. 2020 May 21;382(21):2063
pubmed: 32294374
Lancet. 2015 Sep 12;386(9998):1097-108
pubmed: 26277247
Indoor Air. 2017 Mar;27(2):452-462
pubmed: 27287598
Cochrane Database Syst Rev. 2015 Jul 16;(7):CD007087
pubmed: 26184396
Biointerphases. 2015 Mar 16;11(1):018902
pubmed: 26577181
N Engl J Med. 1995 Dec 14;333(24):1618-24
pubmed: 7477199
Int J Mol Sci. 2020 Sep 24;21(19):
pubmed: 32987946
N Engl J Med. 2014 Feb 6;370(6):543-51
pubmed: 24499212
Int J Nanomedicine. 2021 Jan 11;16:223-235
pubmed: 33469282